Back to HALO
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC → HALO
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$5.3M
Q3 2026
Peak value
$5.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.4M |
| Q4 2025 | $1.6M |
| Q1 2026 | $1M |
| Q2 2026 | $1.8M |
| Q3 2026 | $5.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $5.3M | 105.8K | — | — |
| Q2 2026 | $1.8M | 70.8K | — | — |
| Q1 2026 | $1M | 46.7K | — | — |
| Q4 2025 | $1.6M | 21.2K | — | — |
| Q3 2025 | $1.4M | 21.2K | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$251.9M
$236.6M
$176.7M
$148.6M